about
Demonstration of factor H-like protein 1 binding to Treponema denticola, a pathogen associated with periodontal disease in humans.The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative propertiesHuman Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of an delta inulin adjuvanted recombinant pandemic influenza vaccine.Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvantLoss of complement activation and leukocyte adherence as Nippostrongylus brasiliensis develops within the murine host.The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15.Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman.Molecular analyses of the interaction of Borrelia hermsii FhbA with the complement regulatory proteins factor H and factor H-like protein 1Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.Pulmonary nocardiosis re-visited: experience of 35 patients at diagnosis.INITIAT-E.D.: Impact of timing of INITIation of Antibiotic Therapy on mortality of patients presenting to an Emergency Department with sepsis.Use of an Innovative Personality-Mindset Profiling Tool to Guide Culture-Change Strategies among Different Healthcare Worker Groups.The Epidemiology of Staphylococcus aureus and Panton-Valentine Leucocidin (pvl) in Central Australia, 2006-2010.Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range.Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective.Diversity in glycosaminoglycan binding amongst hMPV G protein lineages.hMPV lineage nomenclature and heparin binding.Proteomic analysis of influenza haemagglutinin-specific antibodies following vaccination reveals convergent immunoglobulin variable region signatures.Junior doctors' preparedness to prescribe, monitor, and treat patients with the antibiotic vancomycin in an Australian teaching hospital.A febrile illness with generalized papular rash involving the palms and soles.FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis.Regulation of C3 deposition on gp120 coated CD4 positive cells by decay accelerating factor and factor H.Repeat endocarditis: analysis of risk factors based on the International Collaboration on Endocarditis - Prospective Cohort Study.In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis.Phylogenetic analysis of viridans group streptococci causing endocarditis.Cloning and analysis of the human complement factor H gene promoter.Detection of mosaic protein mRNA in human astrocytes.Prevalence of macrolide-resistant Mycoplasma pneumoniae in South Australia.Toxocara canis larval excretory/secretory proteins impair eosinophil-dependent resistance of mice to Nippostrongylus brasiliensis.A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein.HIV non-B subtype distribution: emerging trends and risk factors for imported and local infections newly diagnosed in South Australia.Single centre experience with pegylated interferon and ribavirin for hepatitis C: looking back before moving forward.Multimeric interactions between complement factor H and its C3d ligand provide new insight on complement regulation.Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H.Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration.Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis.Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit.Interventions Targeting the Prescribing and Monitoring of Vancomycin for Hospitalized Patients: A Systematic Review Protocol.Surgical antisepsis and the risk of operating theatre fires.
P50
Q24536074-C4217DCA-4AA3-43B7-A227-0AE5ECAB8FE8Q27649067-66906A64-F3B6-4A9B-9179-3DEB7682D8C6Q30389743-195E811D-92C5-4A56-85EB-A309D4807CA8Q30399988-67D6D7F5-C186-4FB3-B786-7684AEDE03F0Q30418297-3705ABA4-0F3B-4858-8165-5C5F483F1A9EQ34111677-837AAEA7-19EA-4F16-B1D6-C3EA1BB59448Q34132121-519A0017-2BBE-4EA0-9AD9-11BB28E5611EQ34359227-115B1A49-4128-47D0-9B3B-800134F2B9A3Q34492633-5B773AD7-8037-4444-9E14-8EA5E4ACFC16Q34621859-D56A3695-1FAE-4A93-93AE-9464E380EF2CQ35157399-82EFCD89-37AD-4859-98E9-9D6D160BD60CQ35595789-42ECFFB4-930A-44A2-872B-1E1EE090464FQ35816275-E94F4618-0800-4E73-B43E-4BB34A8E2622Q36097974-44E11C9C-4445-4321-91AC-96BD6557AE04Q36981191-4A0323A7-C309-474B-AA10-2A7518E55207Q38609374-CD6CCBA6-FB11-4314-8848-FD1DCB5D5E1DQ39225695-1FC17006-1DD0-45F9-B53C-A08F1A9F3EF2Q39330651-1BE8B558-D887-42EF-8C6C-9932495612FBQ40059296-23836427-8FB3-43C5-81E7-4327EE6B0A18Q40138068-75B6B6BB-E4E5-4AE2-96AC-51215D71F682Q40458457-7DBDE1FF-7BC7-41D6-8248-94AB6AC8AFE5Q40583472-49C05D54-3B72-4440-A374-5094034C8820Q41425849-90A89304-2B63-4519-B74E-B217FEBEDDD8Q42245168-A83BDEFF-3B90-4AD9-A958-98620195AC0FQ42254947-D4FF881E-2A6D-4959-85BB-A3B1FE8B32F0Q42752805-E8A2B2B5-717C-434F-92DC-1682AFDEFB94Q43526580-2303CD1F-8EEF-4146-B6F3-0D33F7F0064EQ43552581-2D5EEF11-860C-4AB9-A777-2A143780EB52Q43970437-D0098C39-C9E8-46B5-BED9-80EC3B1C9E39Q44060067-57854692-FEDE-4493-9329-FD01549DFE68Q44387961-E3EC32D7-F499-4138-9375-6296E1C1DE47Q44943997-23C0FADE-B338-46C4-AD2F-D7619D837E4FQ45836877-7D3284FB-134C-46D0-87D7-AB23EDF3D66EQ46124263-8DDE230A-866F-48D0-BD69-21FC2FBB1AB9Q46275942-59BFDE11-4FA1-4DD1-B07D-425D159D5DF6Q46761824-5CACD08B-9C90-40A0-A5D1-8E704428553EQ46826180-E1C926D8-7B1C-4CE0-9884-61CF933EB73EQ46838202-B463A52E-36F6-4672-A34D-02431726605EQ47142517-F265938B-327A-4A83-B9D3-C6B2BEDAE41AQ47851293-1FBB37C9-7874-49EC-9A48-058A49A0959A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David L Gordon
@ast
David L Gordon
@en
David L Gordon
@es
David L Gordon
@nl
David L Gordon
@sl
type
label
David L Gordon
@ast
David L Gordon
@en
David L Gordon
@es
David L Gordon
@nl
David L Gordon
@sl
prefLabel
David L Gordon
@ast
David L Gordon
@en
David L Gordon
@es
David L Gordon
@nl
David L Gordon
@sl
P106
P108
P21
P31
P496
0000-0003-3276-9685